CA Patent

CA3172249A1 — Methods and compositions for treating acute lung injury and acute respiratory distress syndrome

Assigned to Calcimedica Inc · Expires 2021-09-23 · 5y expired

What this patent protects

Compositions and methods related to the treatment of acute lung injury (ALI) and acute respiratory distress syndrome (ARDS) including viral pneumonia through the pharmaceutical manipulation of calcium signaling are disclosed. Such compositions and methods may be used to reduce pr…

USPTO Abstract

Compositions and methods related to the treatment of acute lung injury (ALI) and acute respiratory distress syndrome (ARDS) including viral pneumonia through the pharmaceutical manipulation of calcium signaling are disclosed. Such compositions and methods may be used to reduce pro-inflammatory cytokine releases that may lead to ALI and/or ARDS.

Drugs covered by this patent

Patent Metadata

Patent number
CA3172249A1
Jurisdiction
CA
Classification
—
Expires
2021-09-23
Drug substance claim
No
Drug product claim
No
Assignee
Calcimedica Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.